How should the LAI dose be adjusted after initiation for CrCl 50-80?

How should the LAI dose be adjusted after initiation for CrCl 50-80?

• A. Increase by 1 mg BID
• B. Increase by 0.5 mg BID
• C. Decrease by 0.5 mg BID
• D. Increase by 0.5 mg QD

Answer: (B)

A small, careful uptitration is the approach when adjusting an LAI in the setting of mild renal impairment (CrCl 50–80). With this level of decline in clearance, you want to reach the intended exposure without risking excessive peak levels. Increasing the maintenance dose by 0.5 mg twice daily provides a modest step up that aligns with the gradual, steady-state pharmacokinetics of a long-acting formulation while still respecting the reduced clearance. A larger jump (for example, 1 mg BID) could overshoot tolerability, while decreasing the dose or changing to a lower frequency wouldn’t help achieve the target exposure. Increasing by 0.5 mg twice daily offers the balanced, incremental adjustment needed.

A small, careful uptitration is the approach when adjusting an LAI in the setting of mild renal impairment (CrCl 50–80). With this level of decline in clearance, you want to reach the intended exposure without risking excessive peak levels. Increasing the maintenance dose by 0.5 mg twice daily provides a modest step up that aligns with the gradual, steady-state pharmacokinetics of a long-acting formulation while still respecting the reduced clearance. A larger jump (for example, 1 mg BID) could overshoot tolerability, while decreasing the dose or changing to a lower frequency wouldn’t help achieve the target exposure. Increasing by 0.5 mg twice daily offers the balanced, incremental adjustment needed.